Literature DB >> 27028520

Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48.

Anna Plitt1, Michael D Ezekowitz2, Raffaele De Caterina3, Francesco Nordio4, Nancy Peterson5, Robert P Giugliano4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27028520      PMCID： PMC6490822          DOI： 10.1002/clc.22537

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


× No keyword cloud information.
  14 in total

1.  [Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine].

Authors:  D C Gulba; L Broscaru
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-31       Impact factor: 0.840

Review 2.  Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis.

Authors:  Natale Daniele Brunetti; Nicola Tarantino; Luisa De Gennaro; Michele Correale; Francesco Santoro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

3.  Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis.

Authors:  Babikir Kheiri; Tarek Haykal; Ahmed Abdalla; Mohammed Osman; Sahar Ahmed; Khansa Osman; Ghassan Bachuwa; Mustafa Hassan; Deepak L Bhatt
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 4.  Anticoagulation in atrial fibrillation : Current evidence and guideline recommendations.

Authors:  J W Erath; S H Hohnloser
Journal:  Herz       Date:  2018-02       Impact factor: 1.443

5.  Practical Implementation of Anticoagulation Strategy for Patients Undergoing Cardioversion of Atrial Fibrillation.

Authors:  Andreas Goette; Hein Heidbuchel
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

6.  Clinical Discussions in Antithrombotic Therapy Management : A Delphi Consensus Panel.

Authors:  Gabriello Marchetti; Emanuele Bertaglia; Alberto Camerini; Giuseppe De Angelis; Lucia Filippucci; Antonio Maggi; Sebastiano Marra; Carlo Racani; Carlo Serrati
Journal:  J Atr Fibrillation       Date:  2020-02-28

Review 7.  The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations.

Authors:  Anna Plitt; Sameer Bansilal
Journal:  J Atr Fibrillation       Date:  2017-02-28

8.  Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial.

Authors:  Monika Kozieł; Naab Al-Saady; Søren P Hjortshøj; Assen Goudev; Kurt Huber; Ariel Cohen; James Jin; Michael Melino; Shannon M Winters; Andreas Goette; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2020-01-08       Impact factor: 5.460

Review 9.  Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.

Authors:  S P G van Vugt; M A Brouwer
Journal:  Neth Heart J       Date:  2018-06       Impact factor: 2.380

10.  Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure.

Authors:  Axel Brandes; Harry J G M Crijns; Michiel Rienstra; Paulus Kirchhof; Erik L Grove; Kenneth Bruun Pedersen; Isabelle C Van Gelder
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.